Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Marango Jotin Create: Alert

All | News | Filings
Date FiledTypeDescription
01/05/2023 4 Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 105,000 options to buy @ $2.62, valued at $275.1k
04/25/2022 4 Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 397,199 options to buy @ $5.88, valued at $2.3M
04/25/2022 3 Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 3 on Ikena Oncology, Inc.
01/20/2022 4 Marango Jotin (Senior VP, CFO, and CBO) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 600,000 options to buy @ $1.34, valued at $804k
08/23/2021 4 Marango Jotin (Senior VP, CFO, and CBO) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 200,000 options to buy @ $2.35, valued at $470k
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2020 4/A Marango Jotin (Senior VP, Chief Bus. Officer) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 80,000 shares @ $0
05/07/2020 4/A Marango Jotin (Senior VP, Chief Bus. Officer) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 120,000 shares @ $0
03/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2020 4 Marango Jotin (Senior VP, Chief Bus. Officer) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 400,000 options to buy @ $6.91, valued at $2.8M
06/05/2019 4 Marango Jotin (Senior VP, Chief Bus. Officer) has filed a Form 4 on Aptose Biosciences Inc.
Txns: Granted 80,000 shares @ $0
Granted 320,000 options to buy @ $2, valued at $640k
06/05/2019 3 Marango Jotin (Senior VP, Chief Bus. Officer) has filed a Form 3 on Aptose Biosciences Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy